Symptomatic mitral regurgitation is associated with high morbidity and mortality that can be alleviated partly by surgical mitral valve replacement. However, many patients do not undergo surgery. Transcatheter mitral valve replacement is an appealing option for this selected patient group. This study aimed to examine the effectiveness and safety of transcatheter mitral valve replacement<a href="https://solaci.org/en/2017/01/27/transcatheter-mitral-valve-replacement-for-severe-mitral-regurgitation-a-global-study/" title="Read more" >...</a>
Implant of the Melody Valve in Bioprosthesis
Operators: Carlos Pedra, Rodrigo Costa. Chairpersons: Alejandro Peirone, Luiz Alberto Christiani . Debaters: Luiz Carlos Giuliano, Celia Maria Camelo Silva, Fábio Bergman, Jean Marcelo Ferreira da Silva, Daniel Aguirre, Marcelo Rivarola, German Henestrosa. Broadcasted on June 9, 2016 by TBR Productions.
Transcatheter Valve Thrombosis: Predictors, Incidence, and Events
This study sought to clarify the incidence and predictors of hypoattenuated leaflet thickening (assumed as leaflet thrombosis) imaging in transcatheter bioprosthesis. This study involved 70 consecutive patients who underwent transcatheter aortic valve replacement with the Edwards SAPIEN-XT device and were subjected to follow-up at 6 months and 1 year through multislice computed tomography (CT), echocardiographic data, and<a href="https://solaci.org/en/2017/01/21/transcatheter-valve-thrombosis-predictors-incidence-and-events/" title="Read more" >...</a>
TAVR vs. Surgery: Valve Performance at Five Years (PARTNER I)
The aim of this study was to evaluate the long-term performance of transcatheter aortic valve replacement (TAVR) and surgically-implanted valves through longitudinal echocardiographic follow-up of the PARTNER I trial patients. The study included all patients receiving TAVR or undergoing surgery who had a post-implant echocardiogram at five years analyzed for peak systolic velocity, mean gradient,<a href="https://solaci.org/en/2017/01/13/tavr-vs-surgery-valve-performance-at-five-years-partner-i/" title="Read more" >...</a>
Melody Valve implant in RV-PT Conduit
Congenital Case: Melody Valve (Medtronic) implant in RV-PT Conduit. Operators: Carlos Pedra, Marcelo Ribeiro. Chairpersons: Alejandro Peirone, Luiz Alberto Christiani. Debaters: Luiz Carlos Giuliano, Celia Maria Camelo Silva, Fábio Bergman, Jean Marcelo Ferreira da Silva, Daniel Aguirre, Marcelo Rivarola, German Henestrosa. Broadcasted on June 9, 2016 by TBR Productions.
Valve Thrombosis After TAVR: Larger-Diameter Valves and No Warfarin as Predictors
There are limited data on the incidence, clinical implications, and predisposing factors of valve thrombosis in patients who underwent transcatheter aortic valve replacement (TAVR). This study aimed at determining such information through multislice computed tomography (CT). This trial included 460 consecutive patients who underwent TAVR with a balloon-expandable Edwards Sapien XT or Sapien 3 (Edwards Lifesciences,<a href="https://solaci.org/en/2016/11/13/valve-thrombosis-after-tavr-larger-diameter-valves-and-no-warfarin-as-predictors/" title="Read more" >...</a>
Cerebral Protection in TAVR: Studies Presented at London Valves
SENTINEL One of the new devices assessed at London Valves was Sentinel, which is made up of two independent filters. The larger filter is deployed in the brachiocephalic trunk, and the smaller filter is deployed in the left common carotid artery. The study included 22 patients and the device was deployed successfully in 20 of them<a href="https://solaci.org/en/2016/10/20/cerebral-protection-in-tavr-studies-presented-at-london-valves/" title="Read more" >...</a>
Stroke Predictors in TAVR: CoreValve vs. Sapien
A comprehensive analyzis of cerebrovascular events in major randomized controlled studies on transcatheter aortic valve replacement (TAVR) has shown some interesting data on both risks and timing of stroke in this setting. The study carried out by Dr. Neal Kleiman, reviewed data on stroke and stroke predictors among 3,687 patients included in the CoreValve<a href="https://solaci.org/en/2016/09/21/stroke-predictors-in-tavr-corevalve-vs-sapien/" title="Read more" >...</a>
A Study on Valve Thrombosis After TAVI
This study, presented in Rome at the European Society of Cardiology Congress 2016 and published simultaneously online in the Journal of the American College of Cardiology (JACC), has identified a post-TAVI valve thrombosis rate of 7% using multidetector computerized tomography (CT). However, the vast majority of cases were completely asymptomatic. Previous studies had shown<a href="https://solaci.org/en/2016/09/07/a-study-on-valve-thrombosis-after-tavi/" title="Read more" >...</a>
Transcatheter Mitral Valve Replacement: A New Arrow in the Bow
Original Title: Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry Reference: J Am Coll Cardiol Intv. 2016;9(13):1361-1371. doi:10.1016/j.jcin.2016.04.022 Gentileza del Dr. Agustín Vecchia. The risk underlying the surgical approach to mitral valve replacement in patients with severe mitral annular calcification is high. A<a href="https://solaci.org/en/2016/07/15/transcatheter-mitral-valve-replacement-a-new-arrow-in-the-bow/" title="Read more" >...</a>